Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Core Income Before Taxes: $20,777M in FY2025, up 10.7% from a year earlier.
Latest, FY2025
20,777
Period ended Dec 31, 2025
Change on a year earlier
+10.7%
18,771 in FY2024
History
7 years
Since FY2017
Sources
4
Documents cited below
Where the FY2025 figure comes from
“|| Income before taxes | 16 352 | 3 197 | 552 | 71 | 605 | 20 777 | 18 771”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Core Income Before Taxes ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20,777 | +10.7% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 18,771 | – | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2022 | Dec 31, 2022 | 15,960 | -4.6% | Novartis Form 6-K (0001370368-23-000008) ↗ |
| FY2021 | Dec 31, 2021 | 16,729 | +7.5% | Novartis Form 6-K (0001370368-23-000008) ↗ |
| FY2020 | Dec 31, 2020 | 15,561 | – | Novartis Form 6-K (0001370368-22-000009) ↗ |
| FY2018 | Dec 31, 2018 | 14,164 | +5.3% | Novartis Form 6-K (0001370368-19-000006) ↗ |
| FY2017 | Dec 31, 2017 | 13,447 | – | Novartis Form 6-K (0001370368-19-000006) ↗ |
Cite this data
StockData. (2026). Novartis Core Income Before Taxes ($M), annual FY2017–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-pretax-income
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.